Company Filing History:
Years Active: 1999
Title: Mark David Brennand: Innovator in Platelet-Derived Growth Factor Analogues
Introduction
Mark David Brennand is a notable inventor based in Taunton, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on platelet-derived growth factor analogues. His innovative approach has the potential to impact various medical applications.
Latest Patents
Mark David Brennand holds 1 patent for his invention titled "Platelet-derived growth factor analogues." This invention relates to cyclic platelet-derived growth factor (PDGF) analogues and pharmaceutical compositions thereof. His work in this area showcases his commitment to advancing medical science.
Career Highlights
Brennand is currently associated with Trigen GmbH, where he continues to develop and refine his innovative ideas. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his coworkers include Taki Ahmed Jehanli and Geeta Patel. Their collective expertise contributes to the success of their projects and enhances the innovative environment at Trigen GmbH.
Conclusion
Mark David Brennand is a dedicated inventor whose work on platelet-derived growth factor analogues exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are paving the way for future advancements in medical treatments.